We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toPromotional-and-Misleading-Trial-Results-Summaries-Lay-Summaries-Addressing-the-Elephant-in-the-Room

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Best Practices for Implementing Lay Summaries and Communicating Results to Patients

    Session Chair(s)
      Behtash  Bahador

      Behtash Bahador

      • Senior Manager, Quality and Compliance
      • CISCRP, United States
    Chief concerns from regulators and patient/public/advocate communicates are that trial results summaries (lay language summaries) are non-promotional, unbiased and not misleading. This session presents case studies and reviews strategies to address these concerns in lay summary content including: narrative content, visual content, process and policy and review.
    Learning Objective : Discuss the importance of and coming requirement for describing clinical trial results for the lay audience. Propose methods to address the requirements and discuss specific issues related to writing for a lay audience.
      Barry  Drees, PhD

      Preparing for the Clinical Trial Report Lay Summary

      Barry Drees, PhD

      • Senior Partner
      • Trilogy Writing & Consulting, Germany
      Paulo  Moreira

      Beyond Lay Summaries: A Vision for Comprehensive Post-Trial Communications

      Paulo Moreira

      • Vice President, Global Clinical Operations, Head of External Innovation
      • EMD Serono, Inc., United States
      Behtash  Bahador

      Promotional and Misleading Lay Summaries: Addressing the Elephant in the Room

      Behtash Bahador

      • Senior Manager, Quality and Compliance
      • CISCRP, United States